Literature DB >> 31758181

Extra-Large Gα Protein (XLαs) Deficiency Causes Severe Adenine-Induced Renal Injury with Massive FGF23 Elevation.

Julia Matthias1, Qiuxia Cui1,2, Lauren T Shumate1, Antonius Plagge3, Qing He1, Murat Bastepe1.   

Abstract

Fibroblast growth factor-23 (FGF23) is critical for phosphate and vitamin D homeostasis. Cellular and molecular mechanisms underlying FGF23 production remain poorly defined. The extra-large Gα subunit (XLαs) is a variant of the stimulatory G protein alpha-subunit (Gsα), which mediates the stimulatory action of parathyroid hormone in skeletal FGF23 production. XLαs ablation causes diminished FGF23 levels in early postnatal mice. Herein we found that plasma FGF23 levels were comparable in adult XLαs knockout (XLKO) and wild-type littermates. Upon adenine-rich diet-induced renal injury, a model of chronic kidney disease, both mice showed increased levels of plasma FGF23. Unexpectedly, XLKO mice had markedly higher FGF23 levels than WT mice, with higher blood urea nitrogen and more severe tubulopathy. FGF23 mRNA levels increased substantially in bone and bone marrow in both genotypes; however, the levels in bone were markedly higher than in bone marrow. In XLKO mice, a positive linear correlation was observed between plasma FGF23 and bone, but not bone marrow, FGF23 mRNA levels, suggesting that bone, rather than bone marrow, is an important contributor to severely elevated FGF23 levels in this model. Upon folic acid injection, a model of acute kidney injury, XLKO and WT mice exhibited similar degrees of tubulopathy; however, plasma phosphate and FGF23 elevations were modestly blunted in XLKO males, but not in females, compared to WT counterparts. Our findings suggest that XLαs ablation does not substantially alter FGF23 production in adult mice but increases susceptibility to adenine-induced kidney injury, causing severe FGF23 elevations in plasma and bone. © Endocrine Society 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; fibroblast growth factor-23; heterotrimeric G protein; stimulatory G protein

Mesh:

Substances:

Year:  2020        PMID: 31758181      PMCID: PMC6986553          DOI: 10.1210/endocr/bqz025

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

1.  XL alpha s is a new type of G protein.

Authors:  R H Kehlenbach; J Matthey; W B Huttner
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

2.  The alternative stimulatory G protein alpha-subunit XLalphas is a critical regulator of energy and glucose metabolism and sympathetic nerve activity in adult mice.

Authors:  Tao Xie; Antonius Plagge; Oksana Gavrilova; Stephanie Pack; William Jou; Edwin W Lai; Marga Frontera; Gavin Kelsey; Lee S Weinstein
Journal:  J Biol Chem       Date:  2006-05-02       Impact factor: 5.157

3.  Increased FGF23 protects against detrimental cardio-renal consequences during elevated blood phosphate in CKD.

Authors:  Erica L Clinkenbeard; Megan L Noonan; Joseph C Thomas; Pu Ni; Julia M Hum; Mohammad Aref; Elizabeth A Swallow; Sharon M Moe; Matthew R Allen; Kenneth E White
Journal:  JCI Insight       Date:  2019-02-21

4.  Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.

Authors:  Erica L Clinkenbeard; Taryn A Cass; Pu Ni; Julia M Hum; Teresita Bellido; Matthew R Allen; Kenneth E White
Journal:  J Bone Miner Res       Date:  2016-03-04       Impact factor: 6.741

5.  Calcium regulates FGF-23 expression in bone.

Authors:  Valentin David; Bing Dai; Aline Martin; Jinsong Huang; Xiaobin Han; L Darryl Quarles
Journal:  Endocrinology       Date:  2013-10-18       Impact factor: 4.736

6.  Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.

Authors:  Karina Durlacher-Betzer; Alia Hassan; Ronen Levi; Jonathan Axelrod; Justin Silver; Tally Naveh-Many
Journal:  Kidney Int       Date:  2018-05-31       Impact factor: 10.612

7.  Fibroblast Growth Factor 23 Expression Is Increased in Multiple Organs in Mice With Folic Acid-Induced Acute Kidney Injury.

Authors:  Daniela Egli-Spichtig; Martin Y H Zhang; Farzana Perwad
Journal:  Front Physiol       Date:  2018-10-23       Impact factor: 4.566

8.  The G protein α subunit variant XLαs promotes inositol 1,4,5-trisphosphate signaling and mediates the renal actions of parathyroid hormone in vivo.

Authors:  Qing He; Yan Zhu; Braden A Corbin; Antonius Plagge; Murat Bastepe
Journal:  Sci Signal       Date:  2015-08-25       Impact factor: 8.192

9.  FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

Authors:  Mara Riminucci; Michael T Collins; Neal S Fedarko; Natasha Cherman; Alessandro Corsi; Kenneth E White; Steven Waguespack; Anurag Gupta; Tamara Hannon; Michael J Econs; Paolo Bianco; Pamela Gehron Robey
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule.

Authors:  Anthony A Portale; Martin Y H Zhang; Valentin David; Aline Martin; Yan Jiao; Weikuan Gu; Farzana Perwad
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more
  1 in total

Review 1.  Regulation of FGF23: Beyond Bone.

Authors:  Petra Simic; Jodie L Babitt
Journal:  Curr Osteoporos Rep       Date:  2021-11-10       Impact factor: 5.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.